Related Experiment Video
Updated: Feb 7, 2026

Localized RNAi and Ectopic Gene Expression in the Medicinal Leech
Published on: April 17, 2008
Low-Level Antimicrobials in the Medicinal Leech Select for Resistant Pathogens That Spread to Patients
Lidia Beka1, Matthew S Fullmer1, Sophie M Colston1
1Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut, USA.
Abstract:
Fluoroquinolones (FQs) and ciprofloxacin (Cp) are important antimicrobials that pollute the environment in trace amounts. Although Cp has been recommended as prophylaxis for patients undergoing leech therapy to prevent infections by the leech gut symbiont Aeromonas, a puzzling rise in Cp-resistant (Cpr) Aeromonas infections has been reported. We report on the effects of subtherapeutic FQ concentrations on bacteria in an environmental reservoir, the medicinal leech, and describe the presence of multiple antibiotic resistance mutations and a gain-of-function resistance gene. We link the rise of CprAeromonas isolates to exposure of the leech microbiota to very low levels of Cp (0.01 to 0.04 µg/ml), <1/100 of the clinical resistance breakpoint for Aeromonas Using competition experiments and comparative genomics of 37 strains, we determined the mechanisms of resistance in clinical and leech-derived Aeromonas isolates, traced their origin, and determined that the presence of merely 0.01 µg/ml Cp provides a strong competitive advantage for Cpr strains. Deep-sequencing the Cpr-conferring region of gyrA enabled tracing of the mutation-harboring Aeromonas population in archived gut samples, and an increase in the frequency of the Cpr-conferring mutation in 2011 coincides with the initial reports of CprAeromonas infections in patients receiving leech therapy.IMPORTANCE The role of subtherapeutic antimicrobial contamination in selecting for resistant strains has received increasing attention and is an important clinical matter. This study describes the relationship of resistant bacteria from the medicinal leech, Hirudo verbana, with patient infections following leech therapy. While our results highlight the need for alternative antibiotic therapies, the rise of Cpr bacteria demonstrates the importance of restricting the exposure of animals to antibiotics approved for veterinary use. The shift to a more resistant community and the dispersion of Cpr-conferring mechanisms via mobile elements occurred in a natural setting due to the presence of very low levels of fluoroquinolones, revealing the challenges of controlling the spread of antibiotic-resistant bacteria and highlighting the importance of a holistic approach in the management of antibiotic use.
Insights
Subtherapeutic fluoroquinolone (FQ) contamination in medicinal leeches promotes the rise of ciprofloxacin-resistant (Cpr) Aeromonas. This environmental antibiotic exposure drives resistance in leech symbionts, leading to Cpr Aeromonas infections in patients undergoing leech therapy.
Area of Science:
- Microbiology
- Environmental Science
- Genetics
Background:
- Fluoroquinolones (FQs) are antimicrobials found in the environment.
- Ciprofloxacin (Cp) is used for prophylaxis in leech therapy to prevent Aeromonas infections.
- A rise in Cp-resistant (Cpr) Aeromonas infections has been observed in patients receiving leech therapy.
Purpose of the Study:
- To investigate the effects of subtherapeutic FQ concentrations on bacteria within medicinal leeches.
- To identify the mechanisms and origins of Cp resistance in Aeromonas isolates from leeches and patients.
- To link environmental antibiotic exposure in leeches to clinical resistance in Aeromonas.
Main Methods:
- Comparative genomics of 37 Aeromonas strains (clinical and leech-derived).
- Competition experiments to assess the advantage of Cpr strains.
- Deep-sequencing of the gyrA gene to trace resistance mutations in archived leech samples.
Main Results:
- Subtherapeutic Cp levels (0.01-0.04 µg/ml) in leeches promote Cpr Aeromonas.
- Cpr strains have a competitive advantage even at very low Cp concentrations.
- A specific Cpr-conferring mutation in gyrA increased in leech gut samples around 2011, coinciding with reported patient infections.
- Multiple antibiotic resistance mutations and a gain-of-function resistance gene were identified.
Conclusions:
- Environmental contamination with trace amounts of FQs selects for antibiotic-resistant bacteria in natural reservoirs like medicinal leeches.
- This environmental resistance can emerge and spread, leading to clinical infections.
- Restricting animal exposure to antibiotics and adopting a holistic approach to antibiotic management are crucial for controlling antibiotic resistance.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
08:30One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer...
Antimicrobial Effectiveness
Antibiotic Selection
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Leveling Effect
Resistivity